With this move, adesso is consolidating more than one and a half decades of industry experience with healthcare companies and broad expert knowledge regarding technical processes, regulations, technologies and methods of software development and taking it to a new organisational level. In future, the Life Science business area will enable adesso to advise its customers on any and all questions concerning digitalisation in a separate, specially staffed unit with a professional team. The majority of these adesso industry experts are already certified according to the “Certified Professional for Medical Software” training standard.
These industry insiders are familiar with the different regulatory requirements in the life science and biotechnology industries, the strict quality requirements for the end product and correspondingly the production processes and application systems used.
The new European Medical Device Regulation (MDR) is affecting the entire healthcare sector. Requirements such as ISO13485, GxP, GAMP5 and CSV must also to be taken into consideration for digitalisation projects in the industry.
In the medical technology and pharmaceuticals field, adesso will combine its regulatory and industry-specific expertise with IT know-how to create efficient and agile solutions. In doing so, it draws on technologies from the fields of Artificial Intelligence (AI), Blockchain, Open Source Frameworks or Microsoft.